These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16444855)

  • 1. A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease.
    Oka RK; Szuba A; Giacomini JC; Cooke JP
    Vasc Med; 2005 Nov; 10(4):265-74. PubMed ID: 16444855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm.
    Wilson AM; Harada R; Nair N; Balasubramanian N; Cooke JP
    Circulation; 2007 Jul; 116(2):188-95. PubMed ID: 17592080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb hemodynamics are not predictive of functional capacity in patients with PAD.
    Szuba A; Oka RK; Harada R; Cooke JP
    Vasc Med; 2006 Nov; 11(3):155-63. PubMed ID: 17288121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
    J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot exercise intervention to improve lower extremity functioning in peripheral arterial disease unaccompanied by intermittent claudication.
    McDermott MM; Tiukinhoy S; Greenland P; Liu K; Pearce WH; Guralnik JM; Unterreiner S; Gluckman TJ; Criqui MH; Ferrucci L
    J Cardiopulm Rehabil; 2004; 24(3):187-96. PubMed ID: 15235301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of different supervised exercise regimens on endothelial function in patients with intermittent claudication.
    Delaney CL; Miller MD; Allan RB; Spark JI
    Vascular; 2015 Dec; 23(6):561-9. PubMed ID: 25406267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
    Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
    J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence that low ankle-brachial index is associated with reduced bilateral hip extensor strength and functional mobility in peripheral arterial disease.
    Parmenter BJ; Raymond J; Dinnen PJ; Lusby RJ; Fiatarone Singh MA
    J Vasc Surg; 2013 Apr; 57(4):963-973.e1. PubMed ID: 23246081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial Disease.
    De Haro J; Bleda S; Varela C; Esparza L; Acin F;
    Am J Cardiol; 2016 Jan; 117(2):295-301. PubMed ID: 26651453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication.
    Gresele P; Migliacci R; Arosio E; Bonizzoni E; Minuz P; Violi F;
    J Vasc Surg; 2012 Dec; 56(6):1622-8, 1628.e1-5. PubMed ID: 22963812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication.
    Mohler ER; Gainer JL; Whitten K; Eraso LH; Thanaporn PK; Bauer T
    Vasc Med; 2011 Oct; 16(5):346-53. PubMed ID: 22003000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease.
    Crowther RG; Spinks WL; Leicht AS; Sangla K; Quigley F; Golledge J
    J Vasc Surg; 2008 Feb; 47(2):303-9. PubMed ID: 18241753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
    Andreozzi GM; Leone A; Laudani R; Deinite G; Martini R
    Int Angiol; 2007 Mar; 26(1):12-7. PubMed ID: 17353883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication.
    Delaney CL; Spark JI; Thomas J; Wong YT; Chan LT; Miller MD
    Atherosclerosis; 2013 Jul; 229(1):1-9. PubMed ID: 23557982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.